Results 161 to 170 of about 63,602 (218)

Cost-effectiveness analysis of artificial intelligence-assisted risk stratification of indeterminate pulmonary nodules. [PDF]

PLoS One
Godfrey CM, Leech AA, McGann KC, Zhu J, Marmor HN, Pena S, Pickup LC, Maldonado F, Osmundson EC, Dusetzina SB, Grogan EL, Deppen SA.   +11 more
europepmc   +1 more source

Social health insurance [PDF]

, 2002
Busse, R, Normand, C
core  

Inavolisib-Based Therapy for PIK3CA-Mutated Advanced Male Breast Cancer: A Cost-Effectiveness Analysis. [PDF]

Breast Cancer (Dove Med Press)
Huang X, Lin S, Lin R, Luo S, Huang P, Zeng D.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine for elderly in Zhejiang province, China. [PDF]

Hum Vaccin Immunother
Yu Z, Han S, Hu Y.
europepmc   +1 more source

Cost-effectiveness of percutaneous patent foramen ovale closure versus medical therapy for cryptogenic stroke prevention: A Chinese healthcare perspective. [PDF]

PLoS One
Chen C, Xu T, Zeng Z, Miao J, Hu R, Gao Y, Li C, Li M, Yang X.   +8 more
europepmc   +1 more source

Cost-effectiveness of inavolisib plus palbociclib-fulvestrant versus palbociclib plus fulvestrant as first-line treatment in HR⁺/HER2^-advanced breast cancer. [PDF]

Breast
Zhu J, Ding Y, Li Z, Liu W.
europepmc   +1 more source

Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer. [PDF]

Hum Vaccin Immunother
Yan C, He J, Lv G, Gao Y, Li J, Diao R.
europepmc   +1 more source

Cost-effectiveness of novel antiandrogens for the treatment of nmCRPC patients in the Chinese healthcare system. [PDF]

Ther Adv Urol
Yang W, Zheng B, Zhou M, Li Y, Zheng L, Zhu J, Zhang M.   +6 more
europepmc   +1 more source

Efficacy and cost-effectiveness of VATS versus chest tube drainage in first-episode primary spontaneous pneumothorax with blebs: a propensity score-matched retrospective study. [PDF]

BMC Pulm Med
Lin Q.
europepmc   +1 more source

Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks. [PDF]

Ann Am Thorac Soc
Zheng A, Pletner E, Middelkoop K, Neilan AM, Horsburgh CR, Paltiel AD, Freedberg KA, Wood R, Reddy KP.   +8 more
europepmc   +1 more source